Sharareh Gholamin - Related publications

2012-2017 Neurosurgery Stanford University School of Medicine, Palo Alto, CA, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 García-Heredia JM, Otero-Albiol D, Pérez M, Pérez-Castejón E, Muñoz-Galván S, Carnero A. Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells. Oncogenesis. 9: 96. PMID 33106480 DOI: 10.1038/s41389-020-00280-0   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Li X, Cao K, Deng H, He Y, Liao Q, Xiang B, Zhou M, Guo C, Zeng Z, et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research : Cr. 39: 204. PMID 32993787 DOI: 10.1186/s13046-020-01709-5   
2020 Xu Y, Liu Z, Lv L, Li P, Xiu B, Qian W, Liang A. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8 T lymphocytes in human diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research : Cr. 39: 238. PMID 33168024 DOI: 10.1186/s13046-020-01752-2   
2020 Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, et al. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia (New York, N.Y.). 22: 725-744. PMID 33142238 DOI: 10.1016/j.neo.2020.09.005   
2020 Brossa A, Fonsato V, Grange C, Tritta S, Tapparo M, Calvetti R, Cedrino M, Fallo S, Gontero P, Camussi G, Bussolati B. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. International Journal of Cancer. 147: 1694-1706. PMID 32064610 DOI: 10.1002/ijc.32925   
2020 Nakajima K, Raz A. T cell infiltration profile in musculoskeletal tumors. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 33095470 DOI: 10.1002/jor.24890   
2020 Weddell J, Chiney MS, Bhatnagar S, Gibbs JP, Shebley M. Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology. Clinical and Translational Science. PMID 33073529 DOI: 10.1111/cts.12892   
2020 Li C, Zhou Y, Deng H, Ye Y, Zhao S, Liang S, Cai S, Lin J, Tang Y, Wu Y. Mining database for the therapeutic targets and prognostic biomarkers among STAT family in glioblastoma. Cancer Biomarkers : Section a of Disease Markers. PMID 33104022 DOI: 10.3233/CBM-201746   
2020 Davidov V, Jensen G, Mai S, Chen SH, Pan PY. Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment. Frontiers in Immunology. 11: 1842. PMID 32983100 DOI: 10.3389/fimmu.2020.01842   
2020 Huang X, Cai W, Liu L, Yuan W. Low mutation burden and differential tumor-infiltrating immune cells correlate with lymph node metastasis in colorectal cancer. International Journal of Clinical and Experimental Pathology. 13: 2259-2269. PMID 33042330   
2020 Montoya ML, Kasahara N, Okada H. Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. Neuro-Oncology Practice. 7: 465-476. PMID 33014387 DOI: 10.1093/nop/npaa007   
2020 Jang GY, Kim YS, Lee SE, Lee JW, Han HD, Kang TH, Park YM. Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors. Cancer Immunology, Immunotherapy : Cii. PMID 33113002 DOI: 10.1007/s00262-020-02759-6   
2020 Mueller O, Thomassen J, Wiedemann J, Sure U, Sixt SU. Enzymatic activity of extracellular circulating proteasome in the CSF of patients with malignant intrinsic and metastatic brain tumors: proof of concept. Journal of Neurosurgical Sciences. PMID 32989975 DOI: 10.23736/S0390-5616.20.05112-7   
2020 Kim MY, Shin JY, Kim JO, Son KH, Kim YS, Jung CK, Kang JH. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma. Bmc Cancer. 20: 1057. PMID 33143663 DOI: 10.1186/s12885-020-07566-x   
2020 Vickman RE, Faget DV, Beachy P, Beebe D, Bhowmick NA, Cukierman E, Deng WM, Granneman JG, Hildesheim J, Kalluri R, Lau KS, Lengyel E, Lundeberg J, Moscat J, Nelson PS, et al. Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget. 11: 3621-3632. PMID 33088423 DOI: 10.18632/oncotarget.27736   
2020 Reese B, Silwal A, Daugherity E, Daugherity M, Arabi M, Daly P, Paterson Y, Woolford L, Christie A, Elias R, Brugarolas J, Wang T, Karbowniczek M, Markiewski MM. Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 33158953 DOI: 10.4049/jimmunol.2000511   
2020 Sanchez CE, Dowlati EP, Geiger AE, Chaudhry K, Tovar MA, Bollard CM, Cruz CRY. K Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33007496 DOI: 10.1016/j.bbmt.2020.09.030   
2020 Shofolawe-Bakare OT, Stokes LD, Hossain M, Smith AE, Werfel TA. Immunostimulatory biomaterials to boost tumor immunogenicity. Biomaterials Science. 8: 5516-5537. PMID 33049007 DOI: 10.1039/d0bm01183e   
2020 Champiat S, Tselikas L, Farhane S, Raoult T, Texier M, Lanoy E, Massard C, Robert C, Ammari S, De Baere T, Marabelle A. Intratumoral Immunotherapy: from Trial Design to Clinical Practice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32943460 DOI: 10.1158/1078-0432.CCR-20-0473   
2020 Hu A, Chen X, Bi Q, Xiang Y, Jin R, Ai H, Nie Y. A parallel and cascade control system: magnetofection of miR125b for synergistic tumor-association macrophage polarization regulation and tumor cell suppression in breast cancer treatment. Nanoscale. PMID 33150908 DOI: 10.1039/d0nr06060g   
2020 Metz EP, Wuebben EL, Wilder PJ, Cox JL, Datta K, Coulter D, Rizzino A. Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth. Bmc Cancer. 20: 941. PMID 32998722 DOI: 10.1186/s12885-020-07370-7   
2020 Pohl-Guimarães F, Hoang-Minh LB, Mitchell DA. RNA-electroporated T cells for cancer immunotherapy. Oncoimmunology. 9: 1792625. PMID 33101771 DOI: 10.1080/2162402X.2020.1792625   
2020 Dhodapkar MV, Dhodapkar KM. Tissue-resident memory-like T cells in tumor immunity: Clinical implications. Seminars in Immunology. 101415. PMID 33011063 DOI: 10.1016/j.smim.2020.101415   
2020 Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam ER, Hashemi F, Daneshi S, Hashemi F, Tavakol S, Mohammadinejad R, Najafi M, Dudha N, Garg M. C-Myc signaling pathway in treatment and prevention of brain tumors. Current Cancer Drug Targets. PMID 33069197 DOI: 10.2174/1568009620666201016121005   
2020 Si W, Zhou B, Xie W, Li H, Li K, Li S, Deng W, Shi P, Yuan C, Ke T, Ren X, Tu X, Zeng X, Weigelt B, Rubin BP, et al. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2. Cancer Letters. PMID 33069768 DOI: 10.1016/j.canlet.2020.10.014   
2020 Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nature Communications. 11: 5077. PMID 33033240 DOI: 10.1038/s41467-020-18916-5   
2020 Pimentel VO, Yaromina A, Marcus D, Dubois LJ, Lambin P. A novel co-culture assay to assess anti-tumor CD8 T cell cytotoxicity via luminescence and multicolor flow cytometry. Journal of Immunological Methods. 112899. PMID 33068606 DOI: 10.1016/j.jim.2020.112899   
2020 Ognjenovic NB, Bagheri M, Mohamed GA, Xu K, Chen Y, Mohamed Saleem MA, Brown MS, Nagaraj SH, Muller KE, Gerber SA, Christensen BC, Pattabiraman DR. Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors. Developmental Cell. PMID 33120014 DOI: 10.1016/j.devcel.2020.10.004   
2020 Yuan B, Li F, Li Y, Chen Y. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation. Cancer Management and Research. 12: 4017-4027. PMID 33116819 DOI: 10.2147/CMAR.S250126   
2020 Parker AL, Cox TR. The Role of the ECM in Lung Cancer Dormancy and Outgrowth. Frontiers in Oncology. 10: 1766. PMID 33014869 DOI: 10.3389/fonc.2020.01766   
2020 Zhang SY, Song XY, Li Y, Ye LL, Zhou Q, Yang WB. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy. Pharmacological Research. 105111. PMID 33065284 DOI: 10.1016/j.phrs.2020.105111   
2020 Lin W, Noel P, Borazanci EH, Lee J, Amini A, Han IW, Heo JS, Jameson GS, Fraser C, Steinbach M, Woo Y, Fong Y, Cridebring D, Von Hoff DD, Park JO, et al. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Medicine. 12: 80. PMID 32988401 DOI: 10.1186/s13073-020-00776-9   
2020 Meng X, Liu W, Yang H, Cao Z, He H, Zheng K, Chen Y, Su J, Lv J, Sun J, Li P, Ding S, Ahmad N, Qian J, Zhou Y. Ticagrelor prevents tumor metastasis via inhibiting cell proliferation and promoting platelet apoptosis. Anti-Cancer Drugs. PMID 33009034 DOI: 10.1097/CAD.0000000000000925   
2020 Lv C, Yuan D, Cao Y. . The Journal of Pharmacology and Experimental Therapeutics. PMID 33158943 DOI: 10.1124/jpet.120.000284   
2020 Sabbatino F, Scognamiglio G, Liguori L, Marra A, Anniciello AM, Polcaro G, Dal Col J, Caputo A, Peluso AL, Botti G, Zeppa P, Ferrone S, Pepe S. Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma. Frontiers in Immunology. 11: 561390. PMID 33117345 DOI: 10.3389/fimmu.2020.561390   
2020 Yao JH, Zhang WQ, Shao Y, Zhu Y, Liu J, Jin GS, Yang Y. Molecular phenotype discordance between primary and synchronous metastatic lesions of breast cancer and its determinant role in guiding treatment decisions: a case report. American Journal of Translational Research. 12: 5866-5873. PMID 33042465   
2020 Zhang Y, Guo C, Liu L, Xu J, Jiang H, Li D, Lan J, Li J, Yang J, Tu Q, Sun X, Alamgir M, Chen X, Shen G, Zhu J, et al. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death. Theranostics. 10: 11197-11214. PMID 33042278 DOI: 10.7150/thno.44920   
2020 Jose G, Lu YJ, Hung JT, Yu AL, Chen JP. Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy. Cancers. 12. PMID 33142721 DOI: 10.3390/cancers12113211   
2020 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduction and Targeted Therapy. 5: 228. PMID 33028808 DOI: 10.1038/s41392-020-00313-5   
2020 Huang LT, Tsai CL, Huang SH, Chang MM, Chang WT, Cheng LH, Cheng HC. Depleting RhoA/Stress Fiber-Organized Fibronectin Matrices on Tumor Cells Non-Autonomously Aggravates Fibroblast-Driven Tumor Cell Growth. International Journal of Molecular Sciences. 21. PMID 33158289 DOI: 10.3390/ijms21218272   
2020 Pires A, Greenshields-Watson A, Jones E, Smart K, Lauder SN, Somerville M, Milutinovic S, Kendrick H, Hindley JP, French R, Smalley MJ, Watkins WJ, Andrews R, Godkin A, Gallimore A. Immune Remodelling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection. Cancer Immunology Research. PMID 33023965 DOI: 10.1158/2326-6066.CIR-20-0070   
2020 Zhou H, Qin F, Chen C. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy. Advanced Healthcare Materials. e2001277. PMID 32985141 DOI: 10.1002/adhm.202001277   
2020 Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, Lim Y, Hur M, Lee HW, Choi SW, Nam DH. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers. 12. PMID 33142709 DOI: 10.3390/cancers12113210   
2020 Meng L, Ding P, Liu S, Li Z, Sang M, Shan B. The emerging prospects of circular RNA in tumor immunity. Annals of Translational Medicine. 8: 1091. PMID 33145310 DOI: 10.21037/atm-19-4751   
2020 Hübbe ML, Jæhger DE, Andresen TL, Andersen MH. Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade. Frontiers in Immunology. 11: 578349. PMID 33101304 DOI: 10.3389/fimmu.2020.578349   
2020 Gardell JL, Matsumoto LR, Chinn H, DeGolier KR, Kreuser SA, Prieskorn B, Balcaitis S, Davis A, Ellenbogen RG, Crane CA. Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma. Journal For Immunotherapy of Cancer. 8. PMID 33122397 DOI: 10.1136/jitc-2020-001202   
2020 Liu H, Yang C, Zhao X, Le J, Wu G, Wei J, Liang Y, Qian W. Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. Oncotargets and Therapy. 13: 10797-10806. PMID 33122918 DOI: 10.2147/OTT.S275334   
2020 Sanz-Ortega L, Rojas JM, Barber DF. Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting. Pharmaceutics. 12. PMID 32867162 DOI: 10.3390/pharmaceutics12090812